MedTrace Logo

Surgical Versus Medical Treatment of Acromegaly

NCT01000090 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2015-12-03

No results posted yet for this study

Summary

Evaluate biochemical differences in acromegalic patients treated with surgery versus somatostatin analogues (SMS) (after surgery or alone).

Hypothesis: Treatment modality exhibit different biochemical responses in acromegaly.

Conditions

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Kristine Z Rubeck, stud. med. · Medical department M, Århus University Hospital

  • Jens Otto L Jørgensen, MD · Medical department M, Århus University Hospital

  • Michael Madsen, MD · Medical department M, Århus University Hospital

  • Sanne Fisker, MD · Medical department M, Århus University Hospital

  • Caroline Adreasen, MD · Medical department M, Århus University Hospital

  • Jan Frystyk, MD · Medical department M, Århus University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-02-28
Completion
2011-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01000090 on ClinicalTrials.gov